Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0504-2026

BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341; Recall

BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341;

FDA recall Class II

Ongoing

FDA lists this Class II recall for BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0504-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 14, 2025
FDA report date
Nov 26, 2025
Quantity in commerce
4180000 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341;

Affected model & UDI checker

Search the exact identifiers published for Z-0504-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedBD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341;Check source notice50382903083416
FDA code information

Catalog Number(s) or Model Number(s): 308341; UDI-DI: 50382903083416; Lot Numbers: 5029670, 5034211, 5041975;

View the original FDA recall notice

Why was this product recalled?

BD has confirmed through internal testing that certain device trays failed routine biocompatibility testing.

What actions did Becton Dickinson & Company take?

On October 14, 2025, URGENT: MEDICAL DEVICE REMOVAL letters were sent to distributors and customers. Please Take the Following Actions: 1. Cease use and destroy any unused affected product according to your facilities regulations. BD will provide credit for all product destroyed. 2. Identify all customers within your distribution network that purchased any affected product as defined in this notification. Provide a copy of the attached customer letter to all customers to advise them of this field action notification on BD s behalf. 3. Complete the attached Distributor Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. 4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fisher s Lane, Rockville, MD 20852-9787 5. Report any complaints experienced with the use of this product to BD via the North American Regional Complaint Center: Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Product Complaints when prompted Mon Fri 8:00am and 5:00pm CT Email: [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology